Clinical Trial Results:
            A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 and 200 mg/day) as Adjunctive Therapy in Adults With Major Depression 
Associated With Bipolar I Disorder
    
|     Summary | |
|     EudraCT number | 2009-016634-27 | 
|     Trial protocol | FR BG ES | 
|     Global completion date | 
                                    21 Nov 2012
                             | 
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | 
                                        No
                                 | 
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Results information | |
|     Results version number | v1(current) | 
|     This version publication date | 
                                    16 Nov 2016
                             | 
|     First version publication date | 
                                    16 Nov 2016
                             | 
|     Other versions | |
|     Summary report(s) | C10953-3072 SummaryResults.pdf | 
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
